SHR-1701 Combined with SHR2554 and BP102 for MCRC

NCT06679673 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG: SHR-1701
DRUG: BP102
DRUG: SHR2554

Sponsor

Fudan University